Nvidia's AI Ambitions Span from Pharma to Potential Pitfalls

Nvidia's stock closed Friday at €160.26, holding just above its key moving averages and marking a period of relative stabilization following the hype of its GPU Technology Conference in mid-March. The share price remains roughly eleven percent below its 52-week high of €179.62, yet it boasts a twelve-month gain of nearly 67 percent, underscoring the underlying strength of the AI chipmaker.

This stability is being tested by a high-profile skeptic. Investor Michael Burry, famed for his early bet against the US housing market, has drawn a direct comparison between Nvidia's current trajectory and that of Cisco Systems in 2000, just before the dot-com bubble burst. His warning appears counterintuitive against a backdrop of record-breaking financial performance.

The company's fiscal 2026 results offered little cause for concern, with total revenue hitting $215.9 billion—a 65 percent year-over-year increase. Its data center segment alone contributed $62.3 billion in the fourth quarter, surging 75 percent. Based on forward earnings estimates, Nvidia trades at a price-to-earnings ratio of approximately 21.5, only slightly above the S&P 500 average of 20.3 and considered moderate given its growth rates.

Burry's argument, however, looks beyond the present boom to the financial structure supporting it. He highlights Nvidia's substantial leverage, noting the company carries about $95.2 billion in supply obligations. This could become a vulnerability if demand from major hyperscale cloud providers slows. Adding to the cautionary signal, large hedge funds have recently reduced their Nvidia positions at the fastest pace in over a decade. Burry contends that massive infrastructure spending does not guarantee perpetual revenue growth, a lesson Cisco learned when demand for networking equipment abruptly collapsed.

Simultaneously, Nvidia is aggressively expanding its ecosystem into new verticals, moving beyond pure data center sales. A key focus is the life sciences sector, a promising growth market for AI infrastructure due to the compute-intensive nature of drug discovery, medical imaging, and clinical data analysis. This coming Tuesday, the chip giant will present at the AWS Life Sciences Symposium in New York's Javits Center, showcasing how its high-performance computing platforms can transform pharmaceuticals and healthcare.

This industry-specific push is part of a broader strategic diversification. The company is also engaging developers this weekend at "The Spark Hack" hackathon in New York, where participants will test its acceleration platforms in practical applications. On the industrial front, Siemens announced a breakthrough on April 9, 2026, using Nvidia's architecture to map trillions of pre-silicon design cycles in mere days, significantly accelerating the development of complex AI chips.

Management remains confident about the road ahead, supported by an order backlog for its Blackwell and Vera Rubin chip architectures extending through the end of 2026, with an estimated value exceeding $500 billion. Some analysts see potential for cumulative revenue to reach at least one trillion dollars by 2027. CEO Jensen Huang, speaking at the recent GPU Technology Conference, emphasized a flexible approach to data center networking, advocating for both copper and optical connections as part of a global AI infrastructure build-out he estimates will be worth $3 to $4 trillion by 2030.

Whether Burry's Cisco comparison holds water will become clearer when hyperscalers unveil their investment budgets for 2027. For now, Nvidia's path involves balancing explosive growth in its core business with strategic forays into sectors like healthcare, all while navigating the significant financial leverage and investor skepticism that accompany its dominant market position.

Ad

Nvidia Stock: New Analysis - 13 April

Fresh Nvidia information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nvidia analysis...